GS0411: Education and training, in particular arranging and conducting of seminars and workshops and academic enrichment programs in the field of inflammation medicine for young academics
DM0000: The mark consists of three crescent-shaped curved lines, with the top crescent in blue, the bottom right crescent in red and the bottom left crescent in gray. Beneath the three crescents is the wording "Inflammation at Interfaces" in gray
CC0000: The color(s) red, grey and blue is/are claimed as a feature of the mark.
GS0351: [ Business management and administration, operation of business for others, namely, medical care and research organizations, in particular in the field of inflammation medicine; organization and arrangement of trade exhibitions and trade fairs for scientific businesses, commercial and advertising purposes; business marketing services and public relations; distribution of advertising material; procurement of service contracts for others, namely, procuring of labor contracting services for others ]
GS0441: [ Medical services, in particular medical and clinical analysis in the nature of medical analysis of inflammation medicine and inflammation related conditions; therapeutic and medical treatment and attendance, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, and including analysis of patient's environment, analysis of life circumstances, genetically disposition analysis, and hereditary family analysis; services of a hospital; medical care, namely, medical care for inflammation related conditions ]
D10000: "INFLAMMATION"
GS0421: Scientific services and research activities, in particular scientific research for medical purposes, namely providing medical research, clinical research and interdisciplinary medical research in the field of inflammation medicine, including fundamental research, contract research and clinical trials; pharmaceutical drug development services and conducting clinical trials featuring the application of new therapies and therapy approaches and diagnostic methods for scientific purposes; scientific study and research in the field of inflammation medicine featuring reports and surveys; industrial analysis, namely, conducting technical project studies in the field of high-throughput of molecular diagnostics, and translational and clinical research based on molecular makeup of patients
Case File Event Statements
9/25/2022 - 2 years ago
50 - PARTIAL INVALIDATION PROCESSED BY THE IBType:INNP
8/23/2022 - 2 years ago
49 - GENERIC MADRID TRANSACTION SENT TO IBType:XXSS
8/23/2022 - 2 years ago
48 - GENERIC MADRID TRANSACTION CREATEDType:XXCR
6/25/2022 - 2 years ago
47 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATEDType:INPR
10/25/2021 - 3 years ago
46 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILEDType:NA71